Cargando…

The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer

BACKGROUND: Diabetes mellitus is frequently observed in pancreatic cancer patients and is both a risk factor and an early manifestation of the disease. METHODS: We analysed the prognostic impact of diabetes on the outcome of pancreatic cancer following resection and adjuvant chemotherapy using indiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kleeff, Jörg, Costello, Eithne, Jackson, Richard, Halloran, Chris, Greenhalf, William, Ghaneh, Paula, Lamb, Richard F, Lerch, Markus M, Mayerle, Julia, Palmer, Daniel, Cox, Trevor, Rawcliffe, Charlotte L, Strobel, Oliver, Büchler, Markus W, Neoptolemos, John P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046218/ https://www.ncbi.nlm.nih.gov/pubmed/27584663 http://dx.doi.org/10.1038/bjc.2016.277

Ejemplares similares

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
por: Middleton, Gary, et al.
Publicado: (2016)

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
por: Martinelli, Paola, et al.
Publicado: (2017)

hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
por: Aughton, Karen, et al.
Publicado: (2021)

Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
por: Elander, N. O., et al.
Publicado: (2018)

Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue
por: Bauer, Andrea S., et al.
Publicado: (2012)

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
por: Shaw, Victoria E, et al.
Publicado: (2014)

United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer
por: Oldfield, Lucy, et al.
Publicado: (2022)

Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma
por: Mann, Kulbir, et al.
Publicado: (2019)

Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer
por: Bauer, Andrea S., et al.
Publicado: (2017)

Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer
por: Elander, N. O., et al.
Publicado: (2018)

The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements
por: Ashworth, Milton, et al.
Publicado: (2021)

What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses
por: Sultana, Asma, et al.
Publicado: (2015)

Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer
por: Mahajan, Ujjwal M, et al.
Publicado: (2019)

Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes
por: Oldfield, Lucy, et al.
Publicado: (2022)

S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes
por: Nedjadi, Taoufik, et al.
Publicado: (2018)

Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival
por: Rachakonda, P. Sivaramakrishna, et al.
Publicado: (2013)

Single-Port Retroperitoneal Pancreatic Necrosectomy for the Treatment of Extrapancreatic Walled-Off Necrotic Collections
por: Saunders, Rebecca, et al.
Publicado: (2021)

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
por: Smith, R A, et al.
Publicado: (2011)

Pancreatic Cancer Susceptibility Loci and Their Role in Survival
por: Rizzato, Cosmeri, et al.
Publicado: (2011)

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials
por: Neoptolemos, J P, et al.
Publicado: (2009)

Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
por: Dive, C, et al.
Publicado: (2010)

Severe acute pancreatitis: surgical indications and treatment
por: Heckler, Max, et al.
Publicado: (2020)

Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable Survival
por: Tjaden, Christine, et al.
Publicado: (2023)

Linking COVID-19 and Acute Pancreatitis Through the Pathogenic Effects of the SARS-CoV-2 S Protein Subunit 1 on Pancreatic Stellate Cells and Macrophages
por: Neoptolemos, J P, et al.
Publicado: (2022)

The Value of Source Data Verification in a Cancer Clinical Trial
por: Tudur Smith, Catrin, et al.
Publicado: (2012)

Necrosis, Apoptosis, Necroptosis, Pyroptosis: It Matters How Acinar Cells Die During Pancreatitis
por: Sendler, Matthias, et al.
Publicado: (2016)

The in situ near-total pancreatectomy (LIVOCADO procedure) for end-staged chronic pancreatitis
por: Baron, Ryan D., et al.
Publicado: (2021)

Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker
por: Martinez-Bosch, Neus, et al.
Publicado: (2018)

Long-term survival and cure model following liver resection for breast cancer metastases
por: Ruiz, Aldrick, et al.
Publicado: (2018)

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival
por: Morales-Oyarvide, Vicente, et al.
Publicado: (2017)

Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003)

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
por: Makubate, B, et al.
Publicado: (2013)

Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy
por: Arpino, Grazia, et al.
Publicado: (2015)

Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
por: Habermehl, Daniel, et al.
Publicado: (2015)

Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer
por: Land, L H, et al.
Publicado: (2012)

Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
por: Drooger, Jan C., et al.
Publicado: (2016)

Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen
por: van Nuland, M., et al.
Publicado: (2018)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion
por: Koppelmans, Vincent, et al.
Publicado: (2020)

Pancreatic metastasis of Merkel cell carcinoma and concomitant insulinoma: Case report and literature review
por: Bachmann, Jeannine, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_k2ou7i831lphvhnjuvr01692bv